Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience

Background: Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective: Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method: Unicentric observational retrospective study including adul...

Descripción completa

Detalles Bibliográficos

Autores principales:	A. Martínez-Doménech, V. Zaragoza-Ninet, A. Esteve-Martínez, A. García-Rabasco, J.L. Sánchez-Carazo, A. Pérez-Ferriols
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2024-02-01
Colección:	Actas Dermo-Sifiliográficas
Materias:	Dermatitis atópica Tratamiento dermatológico Dupilumab Eccema Práctica clínica
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S0001731023008189
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!